explore -WSS

explore

author：entertainment 2025-08-24 10:14:52 - browse：16496

Venture capital firm RA Capital is starting a new incubator, setting the stage for the firm to create new startups over the next several years that hone in on synthetic biology, a long-gestating field that insiders say is getting renewed interest.

The Boston-based VC’s incubator is called RASyn, and will be led by Robert Nicol, according to people familiar with the firm’s plans. Nicol spent more than 20 years at the Broad Institute, where he co-founded the MIT-Broad Foundry for Synthetic Biology, as well as HiFiBio Therapeutics and Design Pharmaceuticals.

RA Capital confirmed RASyn’s existence. Senior Managing Director Josh Resnick told STAT it’s part of the firm’s work to rethink how it develops platforms — core technologies or scientific approaches that underpin all of the drugs a biotech develops — but declined to comment further.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Crowdfunding for unproven stem cell procedures spreads misinformation

hotspot

WSS

Novo Nordisk touts Wegovy study, but still struggling with supply

After Optum profits sink, UnitedHealth makes changes

Lupron, used to halt puberty in children, may cause lasting health problems

Health AI: on the border between health care and tech

Security flaws in third

Aspartame and sugar

explore

explore

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

Dozens dead from Maui wildfires: What we know about the victims

Continuity nursing helped my family in our darkest PICU moments

Novo Nordisk touts Wegovy study, but still struggling with supply

ChatGPT in medicine: STAT answers readers' burning questions

Montana youths win climate lawsuit against state for promoting fossil fuels

What does generative AI mean for health care? We asked experts

Skip the lead apron during X

United colonoscopy coverage change 'may cost lives,' doctors say

Skip the lead apron during X

focus

Security flaws in third

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

Patients, digital health players weigh in on FTC's data privacy plan

YouTube cracks down on misinformation on cancer treatment

BMS, looking to build heart drug business, turns to AI for diagnosis

Senators push IRS to launch nonprofit hospital probe

hotspot

hotspot

leisure time

focus